163 related articles for article (PubMed ID: 25310835)
1. T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and TCL1A rearrangement.
Hsi AC; Robirds DH; Luo J; Kreisel FH; Frater JL; Nguyen TT
Am J Surg Pathol; 2014 Nov; 38(11):1468-83. PubMed ID: 25310835
[TBL] [Abstract][Full Text] [Related]
2. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
[TBL] [Abstract][Full Text] [Related]
3. TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients.
Yokohama A; Saitoh A; Nakahashi H; Mitsui T; Koiso H; Kim Y; Uchiumi H; Saitoh T; Handa H; Jimbo T; Murayama K; Sakura T; Murakami H; Karasawa M; Nojima Y; Tsukamoto N
Int J Hematol; 2012 Jan; 95(1):77-85. PubMed ID: 22189846
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotyping of mature T/NK cell neoplasm presenting as leukemia.
Gujral S; Polampalli S; Badrinath Y; Kumar A; Subramanian PG; Nair R; Sengar M; Nair C
Indian J Cancer; 2010; 47(2):189-93. PubMed ID: 20448385
[TBL] [Abstract][Full Text] [Related]
5. Aberrations of MYC are a common event in B-cell prolymphocytic leukemia.
Flatley E; Chen AI; Zhao X; Jaffe ES; Dunlap JB; Pittaluga S; Abdullah S; Olson SB; Spurgeon SE; Fan G
Am J Clin Pathol; 2014 Sep; 142(3):347-54. PubMed ID: 25125625
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous presentation of T-cell prolymphocytic leukemia.
Ventre MO; Bacelieri RE; Lazarchick J; Pollack RB; Metcalf JS
Cutis; 2013 Feb; 91(2):87-91. PubMed ID: 23513557
[TBL] [Abstract][Full Text] [Related]
7. T-cell prolymphocytic leukemia in a 63-year-old female with a pre-existing T-cell large granular lymphocytic leukemia: metachronous T-cell leukemias with discordant subset restrictions (CD4 versus CD8) and distinct clonal identities.
Wei Q; Papavassiliou P; Rehder C; Sebastian S; Wang E
Pathol Res Pract; 2014 Dec; 210(12):1100-5. PubMed ID: 25238936
[TBL] [Abstract][Full Text] [Related]
8. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
[TBL] [Abstract][Full Text] [Related]
9. Generalized leukaemia cutis from a small cell variant of T-cell prolymphocytic leukaemia presenting with exfoliative dermatitis.
Jeong KH; Lew BL; Sim WY
Acta Derm Venereol; 2009; 89(5):509-12. PubMed ID: 19734979
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic characterization of T-cell prolymphocytic leukemia.
Chen X; Cherian S
Am J Clin Pathol; 2013 Nov; 140(5):727-35. PubMed ID: 24124154
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-myc oncoprotein in chronic T cell leukemias.
Maljaie SH; Brito-Babapulle V; Matutes E; Hiorns LR; De Schouwer PJ; Catovsky D
Leukemia; 1995 Oct; 9(10):1694-9. PubMed ID: 7564512
[TBL] [Abstract][Full Text] [Related]
12. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
[TBL] [Abstract][Full Text] [Related]
13. Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition.
Bug S; Dürig J; Oyen F; Klein-Hitpass L; Martin-Subero JI; Harder L; Baudis M; Arnold N; Kordes U; Dührsen U; Schneppenheim R; Siebert R
Cancer Genet Cytogenet; 2009 Jul; 192(1):44-7. PubMed ID: 19480937
[TBL] [Abstract][Full Text] [Related]
14. T-cell prolymphocytic leukemia with a novel translocation (6;11)(q21;q23).
Wong KF; Chan JK; Sin VC
Cancer Genet Cytogenet; 1999 Jun; 111(2):149-51. PubMed ID: 10347553
[TBL] [Abstract][Full Text] [Related]
15. [Cutaneous localization of T-cell prolymphocytic leukemia].
Thomas A; Dompmartin A; Troussard X; Moreau A; Manard C; Leroy D
Ann Dermatol Venereol; 1995; 122(8):526-9. PubMed ID: 8572493
[TBL] [Abstract][Full Text] [Related]
16. A case of T cell prolymphocytic leukemia involving blast transformation.
Ichikawa K; Noguchi M; Imai H; Sekiguchi Y; Wakabayashi M; Sawada T; Komatsu N
Int J Hematol; 2011 May; 93(5):667-672. PubMed ID: 21505955
[TBL] [Abstract][Full Text] [Related]
17. Quantitative flow cytometric identification of aberrant T cell clusters in erythrodermic cutaneous T cell lymphoma. Implications for staging and prognosis.
Horna P; Deaver DM; Qin D; Moscinski LC; Sotomayor EM; Glass LF; Sokol L
J Clin Pathol; 2014 May; 67(5):431-6. PubMed ID: 24319102
[TBL] [Abstract][Full Text] [Related]
18. Expression profiles of MYC protein and MYC gene rearrangement in lymphomas.
Chisholm KM; Bangs CD; Bacchi CE; Molina-Kirsch H; Cherry A; Natkunam Y
Am J Surg Pathol; 2015 Mar; 39(3):294-303. PubMed ID: 25581730
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphatic leukemias of T and NK cell type.
Kingreen D; Siegert W
Leukemia; 1997 Apr; 11 Suppl 2():S46-9. PubMed ID: 9178839
[TBL] [Abstract][Full Text] [Related]
20. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
Le Gouill S; Talmant P; Touzeau C; Moreau A; Garand R; Juge-Morineau N; Gaillard F; Gastinne T; Milpied N; Moreau P; Harousseau JL; Avet-Loiseau H
Haematologica; 2007 Oct; 92(10):1335-42. PubMed ID: 18024371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
